Salmonella expressing detoxified lipopolysaccharide is immunogenic and protective both as an attenuated vaccine and for delivery of foreign antigens. (December 2011)

• Record Type: Journal Article
• Authors: Galen, James E; Simon, Raphael; Ernst, Robert K
• Is Part Of: Expert review of vaccines. Volume 10:Number 12(2011)
• Page Start: 1679
• Page End: 1682
• Publication Date: 2011-12
• Subjects: delayed attenuation -- endotoxin -- foreign antigen -- monophosphoryl lipid A -- protection -- Salmonella -- vaccine; Vaccines -- Periodicals; Vaccination -- Periodicals; 615.37205
• DOI: 10.1586/erv.11.155
• Languages: English
• ISSNs: 1476-0584

Abstract

Evaluation of: Kong Q, Six DA, Roland KL et al. Salmonella synthesizing 1-monophosphorylated lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity. J. Immunol. 187(1), 412–423 (2011). The construction of safe and protective vaccines, derived from human pathogens that have been genetically modified to remove pathogenicity, is often easier to accomplish on paper than it is in the laboratory. Kong and colleagues have pursued a clever strategy to reduce the reactogenicity of attenuated Salmonella oral vaccines by genetically modifying the surface lipopolysaccharide to lower endotoxic activity. The resulting candidate vaccine strains were highly reduced in virulence yet were able to confer protection in a mouse model against challenge with virulent Salmonella . Remarkably, these strains could also be further modified to present foreign antigens from unrelated human pathogens and again confer protection against heterologous challenge. This work brings important new tools to bear on solving the problem of creating efficacious attenuated bacterial vaccines that maximize both safety and immunogenicity in clinical trials.